Immune Checkpoint Inhibition in Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Emerging Mechanisms and Personalized Clinical Strategies.
Saved in:
| Title: | Immune Checkpoint Inhibition in Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Emerging Mechanisms and Personalized Clinical Strategies. |
|---|---|
| Authors: | Nasser NJ; The Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Sindhu KK; The Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Nasser L; Riverdale Kingsbridge Academy, Bronx, NY 10463, USA., Shafaee Z; NYC Health + Hospitals/Elmhurst, Queens, NY 11373, USA., Li J; Department of Chemistry, University of Rochester, Rochester, NY 14627, USA., Resende Salgado L; The Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Li B; Weill Cornell Medicine, New York, NY 10065, USA. |
| Source: | International journal of molecular sciences [Int J Mol Sci] 2025 Sep 04; Vol. 26 (17). Date of Electronic Publication: 2025 Sep 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
